MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3
H.-Y. Cao, C.-H. Xiao, H.-J. Lu, H.-Z. Yu, H. Hong, C.-Y. Guo, J.-F. Yuan Department of Clinical Laboratory, Affiliated Traditional Chinese Medicine Hospital of Nantong University, Nantong, Jiangsu, China.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3, by H.-Y. Cao, C.-H. Xiao, H.-J. Lu, H.-Z. Yu, H. Hong, C.-Y. Guo, J.-F. Yuan, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6478-6485–DOI: 10.26355/eurrev_201908_18531–PMID: 31378887” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/18531
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
H.-Y. Cao, C.-H. Xiao, H.-J. Lu, H.-Z. Yu, H. Hong, C.-Y. Guo, J.-F. Yuan
MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 22
Pages: 11468-11468
DOI: 10.26355/eurrev_202011_23759